BioMérieux (Diagnostic Equipment) Overview
- Year Founded
-
1963
- Status
-
Public
- Employees
-
14,754
- Stock Symbol
-
BIM
- Investments
-
53
- Share Price
-
$129.57
- (As of Thursday Closing)
BioMérieux (Diagnostic Equipment) General Information
Description
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.
Contact Information
Website
www.biomerieux.comCorporate Office
- Campus de lEtoile
- 100 allée Louis Pasteur
- 69280 Marcy-l'Etoile
- France
Corporate Office
- Campus de lEtoile
- 100 allée Louis Pasteur
- 69280 Marcy-l'Etoile
- France
BioMérieux (Diagnostic Equipment) Stock Performance
As of 17-Apr-2025, BioMérieux (Diagnostic Equipment)’s stock price is $129.57. Its current market cap is $15.3B with 118M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $129.57 | $133.58 | $94.59 - $134.70 | $15.3B | 118M | 126K | $3.97 |
BioMérieux (Diagnostic Equipment) Financials Summary
As of 31-Dec-2024, BioMérieux (Diagnostic Equipment) has a trailing 12-month revenue of $4.31B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 13,020,966 | 13,020,966 | 13,239,138 | 12,472,464 |
| Revenue | 4,306,645 | 4,306,645 | 3,976,194 | 3,773,486 |
| EBITDA | 970,643 | 970,643 | 769,464 | 874,137 |
| Net Income | 467,683 | 467,683 | 386,950 | 475,655 |
| Total Assets | 6,004,100 | 6,004,100 | 5,813,519 | 5,562,097 |
| Total Debt | 510,088 | 510,088 | 573,592 | 541,990 |
BioMérieux (Diagnostic Equipment) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioMérieux (Diagnostic Equipment) Comparisons
Industry
Financing
Details
BioMérieux (Diagnostic Equipment) Competitors (22)
One of BioMérieux (Diagnostic Equipment)’s 22 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| DiaSorin | Formerly PE-Backed | Saluggia, Italy | ||||
| Sysmex (Diagnostic Equipment) | Corporation | Kobe, Japan | ||||
| Hologic | Formerly VC-backed | Marlborough, MA | ||||
| QuidelOrtho | Corporation | San Diego, CA |
BioMérieux (Diagnostic Equipment) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioMérieux (Diagnostic Equipment) Patents
BioMérieux (Diagnostic Equipment) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4534684-A1 | Detection and identification of yeasts of the candida genus, methods and tools for microbiology thereof | Pending | 03-Oct-2023 | ||
| EP-4502732-A1 | Method and system for characterizing microorganisms by digital holographic microscopy | Pending | 02-Aug-2023 | ||
| EP-4488658-A1 | Method and system for identifying microorganisms in form of colonies | Pending | 03-Jul-2023 | ||
| EP-4484578-A1 | Method for the detection and confirmation of shigatoxin-producing escherichia coli and/or enterohemorrhagic e. coli | Pending | 29-Jun-2023 | ||
| EP-4484569-A1 | Reaction medium and method for detecting shigatoxin-producing e. coli and/or enterohemorrhagic e. coli | Pending | 29-Jun-2023 | C12Q1/045 |
BioMérieux (Diagnostic Equipment) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioMérieux (Diagnostic Equipment) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioMérieux (Diagnostic Equipment) Investments & Acquisitions (53)
BioMérieux (Diagnostic Equipment)’s most recent deal was a Merger/Acquisition with SpinChip for . The deal was made on 10-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SpinChip | 10-Jan-2025 | Merger/Acquisition | Diagnostic Equipment | ||
| Neoprospecta | 13-Nov-2024 | Merger/Acquisition | Biotechnology | ||
| SpinChip | 13-Mar-2024 | Later Stage VC | Diagnostic Equipment | ||
| Lumed | 08-Jan-2024 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Oxford Nanopore Technologies | 19-Oct-2023 | PIPE | Biotechnology |
BioMérieux (Diagnostic Equipment) ESG
Risk Overview
Risk Rating
Updated September, 19, 2024
20.64 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Healthcare
Industry
of 587
Rank
Percentile
Medical Devices
Subindustry
of 198
Rank
Percentile
BioMérieux (Diagnostic Equipment) Exits (12)
BioMérieux (Diagnostic Equipment)’s most recent exit was on 04-Dec-2017 from Qvella. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Qvella | 04-Dec-2017 | Completed |
|
||
| Knome | 21-Jan-2014 | Completed |
|
||
| Quanterix | 15-Nov-2012 | Completed |
|
||
| Knome | 01-Aug-2011 | Completed |
|
||
| Biocartis | 05-Nov-2010 | Early Stage VC | Completed |
BioMérieux (Diagnostic Equipment) Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Merieux Universite | Tassin-La-Demi-Lune, France | 2012 | |
| Lumed | Sherbrooke, Canada | 2012 | |
| Suzhou Hybiome Biomedical Engineering | Suzhou, China | 2009 | |
| Invisible Sentinel | Philadelphia, PA | 2006 | |
| Ceeram | La Chapelle-sur-Erdre, France | 2005 |
BioMérieux (Diagnostic Equipment) FAQs
-
When was BioMérieux (Diagnostic Equipment) founded?
BioMérieux (Diagnostic Equipment) was founded in 1963.
-
Where is BioMérieux (Diagnostic Equipment) headquartered?
BioMérieux (Diagnostic Equipment) is headquartered in Marcy-l'Etoile, France.
-
What is the size of BioMérieux (Diagnostic Equipment)?
BioMérieux (Diagnostic Equipment) has 14,754 total employees.
-
What industry is BioMérieux (Diagnostic Equipment) in?
BioMérieux (Diagnostic Equipment)’s primary industry is Diagnostic Equipment.
-
Is BioMérieux (Diagnostic Equipment) a private or public company?
BioMérieux (Diagnostic Equipment) is a Public company.
-
What is BioMérieux (Diagnostic Equipment)’s stock symbol?
The ticker symbol for BioMérieux (Diagnostic Equipment) is BIM.
-
What is the current stock price of BioMérieux (Diagnostic Equipment)?
As of 17-Apr-2025 the stock price of BioMérieux (Diagnostic Equipment) is $129.57.
-
What is the current market cap of BioMérieux (Diagnostic Equipment)?
The current market capitalization of BioMérieux (Diagnostic Equipment) is $15.3B.
-
What is BioMérieux (Diagnostic Equipment)’s current revenue?
The trailing twelve month revenue for BioMérieux (Diagnostic Equipment) is $4.31B.
-
Who are BioMérieux (Diagnostic Equipment)’s competitors?
Bio-Rad Laboratories, DiaSorin, Sysmex (Diagnostic Equipment), Hologic, and QuidelOrtho are some of the 22 competitors of BioMérieux (Diagnostic Equipment).
-
What is BioMérieux (Diagnostic Equipment)’s annual earnings per share (EPS)?
BioMérieux (Diagnostic Equipment)’s EPS for 12 months was $3.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
